Exploiting Genome or Epigenome Editing to Functionally Validate Genes or Variants Involved in Substance Use Disorders (R21/R33)

קרןNational Institute on Drug Abuse/NIH
סוגResearch Grants
תאריך אחרון18/12/2020
תאריכים נוספים24/06/2021
פקולטהLife Sciences, Medicine, Social Sciences

The purpose of this initiative is to support projects which exploit genome or epigenome editing to functionally validate and characterize genes or variants involved in substance use disorder-relevant phenotypes.  




Funding: R21 $125,000 per year; R33 $250,000 per year

Duration: R21 2 years; R33 3 years



Research Authority due date: 10 days prior to submission 

LOI (ncouraged) due dates: 24.5.19, 18.11.19, 24.5.20, 18.11.20, 24.5.21, 17.11.21

Full proposal due dates: 24.6.19, 18.12.19, 24.6.20, 18.12.20, 24.6.21, 17.12.21

קבצים מצורפים
עדכון אחרוןעדכון אחרון: 12/05/2019
אוניברסיטת תל-אביב, ת.ד. 39040, תל-אביב 6997801
UI/UX Basch_Interactive